Zhitong Finance App News, Shuanglu Pharmaceutical (002038.SZ) issued an announcement. The company recently received the “Drug Registration Certificate” for bromhexine hydrochloride oral solution (trade name: Beliqing®) approved and issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.